Gambro BCT announces research partnership for application of PET to malaria
Gambro BCT announces research partnership with Walter Reed Army Institute of Research for application of Pathogen Eradication Technology to malaria Research seeks to eliminate malaria from blood supply Stockholm, Sweden, June 29, 2001 - Gambro AB (OM Stockholm Exchange: GAMBaST, GAMBbST), a leading international medical technology and healthcare company, today announced that its wholly owned subsidiary, Gambro BCT, Inc., has signed a cooperative research and development agreement with Walter Reed Army Institute of Research to study the effectiveness of Gambro's riboflavin-based Pathogen